Imipenem-Cilastatin Sodium, a Carbopenem antibiotics product which HISUN Pharmaceutical had spent five year developing was approved in June this year by the State Food & Drug Administration. HISUN became only the second Chinese company to be issued with new drug certificate and production permit after Shenzhen Accordance Pharmaceutical Co., Ltd.
Related News
- Mr. Li Wei, deputy director of state asset regulatory commission of the State Council, came to Hisun
- The First Batch of Oral Solid Preparations of Hisun Pharmaceuticals Export to European Market
- The company has held 2006 shareholders' meeting
- Conch Profile have participated in 2007 annual meeting of plastic doors and windows trade
Photos
More>>
trade
- Neusoft Recognized Again on Global Services 100 List 2006 and also Ranked No. 1
- Intel Capital Signs US$40m Investment Agreement with Neusoft
- Neusoft Listed in The 2007 Global Services 100
- Dr.Liu Jiren Awarded Asia Innovator of the Year at the 6th CNBC Asia Business
- Neusoft CEO Attended the 2010 Summer Davos and Highlighted the New Challenges
market
- Neusoft CEO Dr. Liu Jiren Named Country Winner of Ernst and Young Entrepreneur
- Kaisa Group received 2010 Listed Real Estate Company of the Highest Investment
- Kaisa Group announces interim results for 2010
- Kaisa Group among TOP10 brands of South China real estate companies 6 years in a
- Kaisa Group earned PRC best employer title for 2010
finance
- Campus recruitment for 2011 graduates started with Shenzhen University
- Kaisa Group named among Most Valuable PRC Listed Blue-chip Real Estate Companies
- Kaisa Group ranks 5th among TOP 10 China-Affiliated HK-Listed Companies of
- Insigma being awarded the Grand Prize for Y2009 International Service Outsourcin
- Insigma Continues to Hold 2nd Place in China s Software Outsourcing Industry in